P
PROCEPT BioRobotics Corporation
PRCT · NASDAQ · Healthcare · 1.2B
Price · close
$21.68
+4.58% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.3×
Enterprise value / EBITDAEV/EBITDA
-11.7×
Free cash flow yieldFCF yield
-4.8%
Return on equityROE
-26.1%
Operating margin
-33.7%
Net debt / EBITDAbalance-sheet strength
2.4×
Interest coverage
-29.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.